✦ LIBER ✦

A placebo-controlled crossover trial of the ±4β2 nicotinic acetylcholine receptor partial agonist varenicline in Alzheimer's disease

✍ Scribed by Kim, Seong Yoon; Choi, Seong; Kupiec, James; Schwam, Elias; Rollema, Hans; Jacobsen, Janice; Dubrava, Sarah; McRae, Thomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, placebo-controlled trial o

✍ Shih-Tzu Tsai; Hong-Jun Cho; Huey-Shinn Cheng; Cheol-Hwan Kim; Kuang-Chieh Hsueh 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 229 KB

The α4β2 nicotinic acetylcholine-recepto

✍ Eoin C. O’Connor; Dale Parker; Hans Rollema; Andy N. Mead 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 416 KB

Effect of β2-adrenergic receptor polymor

✍ Michael E Wechsler; Susan J Kunselman; Vernon M Chinchilli; Eugene Bleecker; Hom 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 244 KB

A randomized, double-blind, placebo-cont

✍ Aurelija Jucaite, John Öhd, Alexandra S. Potter, Judith Jaeger… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB

P2-3 THE EFFICACY AND TOLERABILITY OF VA

✍ Dae-Hyun Kim; Shih-Tzu Tsai; Hong-Jun Cho; Wen-Dau Chang; Cheol-Hwan Kim; Huey-S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Efficacy and tolerability of varenicline

✍ Masakazu Nakamura; Akira Oshima; Yoko Fujimoto; Nami Maruyama; Taro Ishibashi; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 244 KB